Business Context and Reporting Period
This Form 8-K Current Report is filed by Shoulder Innovations, Inc. (a Delaware corporation and emerging growth company) on February 26, 2026. The report discloses material changes to the Company's Board of Directors, specifically the resignation of a director and the appointment of a new director, effective immediately on the date of the report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance metrics.
Material Changes
- Director Resignation: Geoff Pardo resigned as a Class I director, member of the Compensation Committee, and Chair of the Nominating and Corporate Governance Committee. The resignation was not due to any disagreement with management or the Board regarding operations, policies, or practices.
- Director Appointment: Andrew Hykes (age 53) was appointed as a Class I director and member of the Compensation Committee to fill the vacancy left by Mr. Pardo.
- Independence: The Board determined Mr. Hykes is an independent director satisfying all applicable requirements for the Compensation Committee under NYSE and Exchange Act rules.
Outlook, Risks, and Management Commentary
Management Commentary: The Company issued a press release on March 2, 2026, announcing these governance changes. Mr. Hykes will receive compensation under the existing Non-Employee Director Compensation Program and will enter into the standard indemnification agreement.
Background of New Director: Mr. Hykes brings significant medical device industry experience, having served as President and CEO of Okami Medical, Inc. (since October 2025), and previously as CEO of Inari Medical, Inc. (2023–2025). His prior roles include leadership positions at Sequent Medical Inc. and Medtronic PLC.
Risks and Contingencies: The filing states there are no arrangements or understandings between Mr. Hykes and other persons regarding his selection, and he holds no material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the effective date of the Board composition change (February 26, 2026).
- Confirm Mr. Hykes' independence status and qualifications for the Compensation Committee.
- Review the attached Press Release (Exhibit 99.1) for additional context on the leadership transition.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial performance.